Ketoprofen lysinate (Oral administration, 10 mg/kg, three times a week for 10 weeks, HFD-induced obese C57BL/6 mice) decreases in relative body weight (15.41%), the iWAT mass (approximately 41%), and leptin (58.68%) and resistin (12.88%)[2].
Ketoprofen lysinate (50 mg/kg, LPS-treated dairy cows) lowers the increase of somatic cell count (SCC), serum albumin (SA), IgG and lactate dehydrogenase (LDH) activity in milk induced by LPS[3].
| Animal Model: | HFD-induced obese C57BL/6 mice[2] |
| Dosage: | 10 mg/kg |
| Administration: | Oral administration, three times a week for 10 weeks |
| Result: | Decreased in relative body weight, the iWAT mass, and the level of leptin and resistin. |
| Animal Model: | LPS (0.2 μg/mL)-treated dairy cows [3] |
| Dosage: | 50 mg/kg |
| Administration: | Injection (Milk samples were taken every 30 min until 6 and 9 h) |
| Result: | Lowered the increase of somatic cell count (SCC), serum albumin (SA), IgG and lactate dehydrogenase (LDH) activity in milk. |
